BridgeBio have substantially boosted its course of an innovative therapy for cardiac amyloidosis, employing the investigational drug. Initial patient results indicates significant improvements for those diagnosed by a https://biotech668140.full-design.com/bridgebio-advances-amyloidosis-therapy-using-the-drug-84770411